Author

Natalie E. R. Beveridge

Observed names: Beveridge, N, Beveridge, N E R, Beveridge, Natalie, Beveridge, Natalie E R, N. E. R. Beveridge, Natalie Beveridge, Natalie E R Beveridge, Natalie E.R. Beveridge, Natalie ER Beveridge, Natalie E. R. Beveridge

Institution: Whiston Hospital

Observed institutions: University of Liverpool, Mersey and West Lancashire Teaching Hospitals NHS Trust, Churchill Hospital, Royal Liverpool and Broadgreen University Hospital NHS Trust, University of Oxford, Broadgreen Hospital, Whiston Hospital, Jenner Institute, Health Protection Agency, Colorado State University

ORCID: 0000-0002-1160-2600

Observed ORCID: 0000-0002-1160-2600

OpenAlex ID: A5081106244

Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populations

2007 · Natalie E. R. Beveridge, David A. Price, et al. · European Journal of Immunology · 226

Establishment of an Aerosol Challenge Model of Tuberculosis in Rhesus Macaques and an Evaluation of Endpoints for Vaccine Testing

2010 · S. A. Sharpe, H. McShane, et al. · Clinical and Vaccine Immunology · 131

Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis –infected Individuals

2009 · Clare R. Sander, Ansar A. Pathan, et al. · American Journal of Respiratory and Critical Care Medicine · 125

Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials

2007 · Ansar A. Pathan, Clare R. Sander, et al. · PLoS ONE · 64

PDF

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults

2011 · Angela M Minassian, Rosalind Rowland, et al. · BMJ Open · 50

PDF

Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining

2010 · Steven G Smith, Maeve K Lalor, et al. · BMC Immunology · 48

PDF

A comparison of IFNγ detection methods used in tuberculosis vaccine trials

2008 · Natalie E.R. Beveridge, Helen A. Fletcher, et al. · Tuberculosis · 45

Th1/Th17 Cell Induction and Corresponding Reduction in ATP Consumption following Vaccination with the Novel Mycobacterium tuberculosis Vaccine MVA85A

2011 · Kristin L. Griffiths, Ansar A. Pathan, et al. · PLoS ONE · 40

PDF

The effectiveness of revaccination with pneumococcal polysaccharide vaccine for preventing pneumococcal disease in older adults in England: A population-based cohort study

2024 · Klara Doherty, Laura Bonnett, et al. · Vaccine · 6

Metastatic melanoma to the heart causing ventricular tachycardia: looking beyond the troponin

2022 · Jack Goodall, Natalie E R Beveridge, et al. · BMJ Case Reports · 1

Economic and environmental impact of reducing unnecessary coagulation screen testing on an acute medical unit: a quality improvement project

2026 · Magda Nasher, Natalie Beveridge, et al. · Postgraduate Medical Journal

Evidence for non-specific effects of live Shingles vaccination against all-cause death and hospitalisation in older adults in England: a population-based cohort study

2025 · Klara Doherty, Natalie E.R. Beveridge, et al. · medRxiv

PDF

Coming soon… Crimean Congo haemorrhagic fever

2017 · Nicholas J. Beeching, Tom Fletcher, et al.

Correction: Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populations

2011 · Natalie E. R. Beveridge, David A. Price, et al. · European Journal of Immunology

PDF

Correction: Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials

2011 · Ansar A. Pathan, Clare R. Sander, et al. · PLoS ONE

PDF

CD4 T cell response to MVA85A vaccination against Mycobacterium tuberculosis in healthy HIV-infected adults

2011 · Natalie E. R. Beveridge, A Minassian, et al. · Immunology

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challengeCD4 T cell response to MVA85A vaccination against Mycobacterium tuberculosis in healthy HIV-infected adults SO IMMUNOLOGY CT Annual Congress of the British-Society-for-Immunology CY DEC 05-08, 2011 CL Liverpool, ENGLAND SP British Soc Immunol

2011 · K Griffiths, Elena Stylianou, et al.

Works count: 22

Citation count: 736

H-index: 8

I10-index: 8